WING ON CO(00289.HK)预计年度由盈转亏4.69亿港元
格隆汇2月3日丨WING ON CO(00289.HK)公告,公司预计截至2020年12月31日止年度录得应拨归股东亏损约为4.69亿港元,相对比2019年同期则为溢利7.66亿港元。该亏损主要由于截至2020年12月31日止年度集团录得投资物业未实现估值净损失约为9亿港元,相对比2019年同期则录得估值净收益3.03亿港元。
如不计算集团投资物业未实现估值净损失及有关递延税项,集团于2020年12月31日止年度的应拨归股东基本溢利预期会相对比2019年同期减少约22.0%。董事们认为于年内集团应拨归股东基本溢利预期减少主要由于2020年1月起爆发COVID-19大流行病疫情所产生的不利影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.